MedCrave Group LLC is a participating organization of the ORCiD proposal and authors are necessary to present their ORCiD figures at submission whenever available.


ORCiD is the source of a determined digital identifier that is unique to you. This differentiates you from every other researcher, which is important when others encompass the identical or similar names. Incorporation in manuscript and grant submission it supports robotic relationship between you and your professional actions guarantee that your work is familiar, and you acquire credit wherever it is outstanding.

Getting an ORCiD id is easy, quick and free to do through the ORCiD registration page:


What are the advantages to authors having an ORCiD iD?

Frequently lots of researchers having similar name, even there is also researchers who possibly will transform their name or publish with dissimilar names in their career. By having ORCiD iD, people will be properly associated with their research work only. Also if you use your ORCiD iD during initial submission process and grant Crossref permission, we will update your ORCiD evidence whenever you publish an article with us.

Crossref will send a notification to your ORCiD inbox requesting permission to update your your ORCiD evidence whenever you publish an article with us.

Crossref will send a notification to your ORCiD inbox requesting permission to update your ORCiD record with your published article. Please see:

https://www.crossref.org/community/orcid/for more information.



Our articles are featured on many websites


MedCrave journals providing ORCiD id to all accepted manuscripts

Click here

Plagiarism checking

Ithenticate logo

MedCrave journals uses iThenticate to check all submitted manuscripts for plagiarism

Click here


It is an honour for me to serve as an author and a reviewer of Urology & Nephrology Open Access Journal, the journal take it's place quickly in the open access medical publication, with growing number of quality articles, I have to congratulate the editorial staff for rapid review process and fast publication.....

Mohammed Mahdi Babakri

Having been given the honor of EMIJ’s editor, it’s my deep pleasure to express my gratitude and compliments to the entire working crew, who has been offering unimpeded efforts with tremendous honesty and professionalism to pursue the frontline in the field of endocrinology and metabolic disorders, and could achieve versatile aspects of s....

Saadi Al-Jadir


© 2014-2018 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
Creative Commons License Open Access by MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at http://medcraveonline.com
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera |Privacy Policy